Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Galera Therapeutics, Inc. (GRTX)  
$0.18 0.00 (-0.51%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 24,810,000
Market Cap: 4.34(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.0903 - $3.42
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Galera Therapeutics is a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of therapeutics that have the potential to transform radiotherapy in cancer. Co. utilizes its capabilities in superoxide dismutase mimetics to design drugs to reduce normal tissue toxicity from radiotherapy and to increase the anti-cancer efficacy of radiotherapy. Co.'s product candidate, avasopasem manganese, GC4419, is a selective small molecule dismutase mimetic that is developing for the reduction of severe oral mucositis. Co.'s another dismutase mimetic product candidate, GC4711, is to increase the anti-cancer efficacy of stereotactic body radiation therapy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 2,462,257 3,394,659 3,394,659 3,515,659
Total Buy Value $529,976 $696,393 $696,393 $908,823
Total People Bought 1 1 1 4
Total Buy Transactions 3 9 9 12
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 92
  Page 2 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   West Linda Director   –       •      –    2021-05-28 4 B $8.64 $86,410 D/D 10,000 10,000 2.39 -9%     
   Sorensen Mel President and CEO   •       •      –    2021-03-26 4 OE $1.07 $235,492 D/D 217,015 232,044     -
   Novo A/s 10% Owner   –       –       •   2021-02-18 4 S $10.58 $5,290,000 D/D (500,000) 2,459,021 11%     
   Alleva Lawrence M Director   –       •      –    2020-11-13 4 B $10.22 $23,771 D/D 2,325 6,325 2.39 -9%     
   Sussman Joel F. Chief Accounting Officer   •       –      –    2020-11-13 4 S $10.32 $103,197 D/D (10,000) 0 9%     
   Sussman Joel F. Chief Accounting Officer   •       –      –    2020-11-13 4 OE $1.07 $14,552 D/D 10,000 10,000     -
   Sussman Joel F. Chief Accounting Officer   •       –      –    2020-11-12 4 S $10.06 $100,627 D/D (10,000) 0 6%     
   Sussman Joel F. Chief Accounting Officer   •       –      –    2020-11-12 4 OE $1.07 $10,700 D/D 10,000 10,000     -
   Holmlud Jon T Chief Medical Officer   •       –      –    2020-10-26 4 AS $15.00 $33,660 D/D (2,244) 0 -17%     
   Holmlud Jon T Chief Medical Officer   •       –      –    2020-10-26 4 OE $2.43 $5,453 D/D 2,244 2,244     -
   Novo A/s 10% Owner   –       –       •   2020-10-15 4 S $11.00 $4,950,000 D/D (450,000) 2,959,021 15%     
   Holmlud Jon T Chief Medical Officer   •       –      –    2020-10-06 4 AS $12.00 $126,432 D/D (10,536) 0     -
   Holmlud Jon T Chief Medical Officer   •       –      –    2020-10-06 4 OE $1.07 $11,668 D/D 10,536 5,632     -
   Holmlud Jon T Chief Medical Officer   •       –      –    2020-10-05 4 AS $12.00 $1,200 D/D (100) 0 3%     
   Holmlud Jon T Chief Medical Officer   •       –      –    2020-10-05 4 OE $1.07 $107 D/D 100 100     -
   Novartis Ag Former 10% Owner   –       –      –    2020-06-19 4 S $8.25 $8,260,824 D/D (1,001,312) 2,467,961 4%     
   Novartis Ag Former 10% Owner   –       –      –    2020-06-18 4 S $9.04 $8,136 D/D (900) 3,469,273 2%     
   Novartis Ag 10% Owner   –       –       •   2020-06-17 4 S $9.27 $42,846 D/D (4,622) 3,470,173 -3%     
   Novartis Ag 10% Owner   –       –       •   2020-06-16 4 S $9.30 $79,980 D/D (8,600) 3,474,795 -25%     
   Novartis Ag 10% Owner   –       –       •   2020-06-15 4 S $9.05 $55,784 D/D (6,164) 3,483,395 -42%     
   Novartis Ag 10% Owner   –       –       •   2020-06-12 4 S $9.19 $13,785 D/D (1,500) 3,489,559 -40%     
   Novartis Ag 10% Owner   –       –       •   2020-06-11 4 S $9.21 $66,312 D/D (7,200) 3,491,059 -34%     
   Novartis Ag 10% Owner   –       –       •   2020-06-10 4 S $9.46 $80,713 D/D (8,532) 3,498,259 -29%     
   Novartis Ag 10% Owner   –       –       •   2020-06-09 4 S $9.38 $65,660 D/D (7,000) 3,506,791 -23%     
   Novartis Ag 10% Owner   –       –       •   2020-06-08 4 S $9.66 $54,666 D/D (5,659) 3,513,791 -24%     
  92 Records found
  1  2  3  4   
  Page 2 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us